Claude Fable 5 Cuts Biology Fallbacks 85% as Safeguards Still Block Dual-Use Research
Updated
Updated · Anthropic · Aug 7
Claude Fable 5 Cuts Biology Fallbacks 85% as Safeguards Still Block Dual-Use Research
3 articles · Updated · Anthropic · Aug 7
Summary
Anthropic said updated biology safeguards for Claude Fable 5 cut biology-related fallbacks by about 85% in testing, allowing many more everyday health, education and some clinical queries to stay on the stronger model.
The change came from rewriting the biology classifier’s rules, retraining it on new data and validating that it still flags harmful or dual-use requests while carving out more benign uses.
Fable 5 still reroutes virology, toxicology, molecular design and other dual-use professional biology requests to Opus 5, meaning it remains unavailable for professional biology research and drug development.
Anthropic said it launched Fable 5 with broad biology blocks because the model can outperform experts on some complex tasks and could materially aid biological weapons work if misused.
Across products, the company expects total fallbacks to drop roughly 67% on Claude.ai, 55% on Cowork, 17% on Claude Code and 7% on the Claude Platform.